The Trusted Provider of Scientific
and Laboratory Services

Find a solution that will work for you.

新着情報
5/12/2016 - 2016​​​​年​6​月​7​日 10時 ~ 16時​45​分迄 ​​バイオリライアンス・セミナー ~ バイオ医薬品・遺伝子治療に関わる最新のアップデート
​この度は、バイオ医薬品製造ならびに遺伝子治療に関わる最新のアップデートというお題で



ニュース

10/16/2014 - BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy ST. LOUIS – October 16, 2014 – BioReliance® (www.bioreliance.com), Sigma-Aldrich Corporation’s (NASDAQ: SIAL) biologics and early-development services business under SAFC® Commercial (www.sigmaaldrich.com/safc), has introduced select in vitro ADME (absorption, distribution, metabolism and excretion) and toxicology testing services for pharmaceutical, chemical and industrial consumer products to its service offering. The broad set of highly predictive assays use a novel suite of genetically modified cell lines created with CompoZr® zinc finger nuclease (ZFN), a Sigma-Aldrich proprietary technology.

ニュース一覧を見る


イベント予定

7 Jun, 2016 - BioReliance Technical Seminar: Essential Updates for Biologics Manufacturers

イベント一覧を見る
試験・サービスをお探しですか?

検索はこちらから


例: Mycoplasma

お問い合わせはこちらへ

Tel: 03-5796-7430

jpinfo@bioreliance.com